ate phase II study of NS-304 in patients with intermittent claudication (IC) resulting from arteriosclerosis obliterans (ASO)
Phase 2
Recruiting
- Conditions
- Arteriosclerosis obliterans (ASO)
- Registration Number
- JPRN-jRCT2031210497
- Lead Sponsor
- Higashioka Masaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1.Patients with intermittent claudication (IC) resulting from arteriosclerosis obliterans (ASO)
2.Patients whose ABI is not more than 0.90 at rest.
3.Patients whose mean PWT measured in the treadmill exercise test meets selection criteria.
Exclusion Criteria
Patients who have severe ischemia of lower extremities of Stage III or over in Fontaine classification or potentially has severe ischemia of lower extremities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method